First-in-human safety and pharmacokinetic evaluation of seralutinib, an investigational inhaled tyrosine-protein kinase inhibitor for pulmonary hypertension

Applied Thermal Engineering · Elsevier

Аннотация

Publication date: December 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 95 Author(s): Jianke Li, Lawrence S. Zisman, Matt Cravets, Richard Aranda

Читать у издателя →

Похожие статьи